Johns Hopkins to launch trials of blood plasma treatment for COVID-19
May 7 (UPI) -- Johns Hopkins University will start two clinical trials of convalescent blood plasma for treatment of COVID-19, the disease caused by the new coronavirus.
May 7 (UPI) -- Johns Hopkins University will start two clinical trials of convalescent blood plasma for treatment of COVID-19, the disease caused by the new coronavirus.